Inbal Hazan-Halevy

The Center of Nanoscience and Nanotechnology, Tel Aviv University

Affiliated withTel Aviv University tel aviv university

Research Area

Biography

Inbal Hazan-Halevy has not added Biography.
If you are Inbal Hazan-Halevy and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2016

Other Publications

Article	Year
Stimulation of NADPH oxidase by angiotensin II in human neutrophils is mediated by ERK, p38 MAP-kinase and cytosolic phospholipase A2. Journal of hypertension\| PubMed ID: 15894894	2005
WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Cancer research\| PubMed ID: 18056455	2007
The effects of natural antioxidants from tomato extract in treated but uncontrolled hypertensive patients. Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy\| PubMed ID: 19052855	2009
Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells. Cancer research\| PubMed ID: 19383925	2009
STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells. Blood\| PubMed ID: 20154216	2010
Kit inhibitor APcK110 extends survival in an AML xenograft mouse model. Investigational new drugs\| PubMed ID: 20517635	2011
The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells. Investigational new drugs\| PubMed ID: 20533075	2011
STAT-3 activates NF-kappaB in chronic lymphocytic leukemia cells. Molecular cancer research : MCR\| PubMed ID: 21364020	2011
Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1. Leukemia & lymphoma\| PubMed ID: 21649540	2011
The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 22140262	2012
Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia. Leukemia & lymphoma\| PubMed ID: 22242820	2012
Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia. Annals of hematology\| PubMed ID: 22349724	2012
Divergence in CD19-mediated signaling unfolds intraclonal diversity in chronic lymphocytic leukemia, which correlates with disease progression. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 23241880	2013
Personalized medicine in CLL: current status and future perspectives. Cancer letters\| PubMed ID: 23879961	2014
Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells. Blood\| PubMed ID: 24778152	2014
STAT3-activated GM-CSFRα translocates to the nucleus and protects CLL cells from apoptosis. Molecular cancer research : MCR\| PubMed ID: 24836891	2014
Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes. Cancer letters\| PubMed ID: 25933830	2015
Metabolism pathways in chronic lymphocytic leukemia. Leukemia & lymphoma\| PubMed ID: 26643954	2016
Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 26699502	2016